期刊文献+

基于网络药理学的黄精丸干预糖脂代谢紊乱机制研究 被引量:4

Mechanism of Huangjing Pill on improving disorder of glycolipid metabolism based on network pharmacology
原文传递
导出
摘要 目的:探究黄精丸干预糖脂代谢紊乱的机制。方法:从中医药百科全书(ETCM)等数据库和相关文献搜集成分,根据胃肠吸收、P-糖蛋白底物和成药性模拟筛选活性成分,从SwissTargetPrediction等数据库搜集靶点,使用Cytoscape软件构建成分-靶点网络,并进行蛋白相互作用网络分析、GO功能富集和KEGG通路分析。结果:甾体皂苷类是黄精丸的主要活性成分,作用于由磷脂酰肌醇-3-激酶(PI3K)、信号转导和转录激活因子3(STAT3)等69个靶点构成的蛋白网络。靶点富集成蛋白质丝氨酸/苏氨酸激酶活动、PI3K-蛋白激酶B(PI3K-AKT)等通路。结论:网络药理学初步表明黄精丸调节糖脂代谢可能是通过甾体皂苷类成分,影响PI3K和STAT3等靶点,进一步影响蛋白质丝氨酸/苏氨酸活动、PI3K-AKT信号等通路。 Objective: To investigate the mechanism of Huangjing Pill on improving the disorder of glycolipid metabolism. Methods: Components were obtained from databases such as ETCM and related literatures. GI-absorption, P-gp substrate and drug-likeness were employed to screen out the active components. Databases such as SwissTargetPrediction were used to predict targets. Cytoscape software was used to establish component-target network, and the protein-protein interaction network analysis, GO function enrichment and KEGG pathway analysis were performed. Results: Steroidal saponins were the main active ingredients of Huangjing Pill, acting on the protein network composed of 69 targets including phosphatidylinositol-3-kinase(PI3 K), signal transducer and activator of transcription 3(STAT3)and so on. These targets were significantly enriched into protein serine/threonine kinase activity, phosphatidylinositol-3-kinase-protein kinase B(PI3 K-AKT)signaling pathway and other pathways. Conclusion: Network pharmacology reveals that steroidal saponins in Huangjing Pill play a role in glycolipid metabolism by influencing PI3 K, STAT3 and other targets as well as protein serine/threonine activity and PI3 K-AKT signal pathway.
作者 陶雅婷 李凤娇 杨敏 张铮洋 秦盼月 穆健康 杨兴鑫 顾雯 陈真 俞捷 TAO Yating;LI Fengjiao;YANG Min;ZHANG Zhengyang;QIN Panyue;MU Jiankang;YANG Xingxin;GU Wen;CHEN Zhen;YU Jie(College of pharmaceutical science,yunnan university of chinese medicine,kunming 650500.yunnan,china;Biomedical engineering research center,kunming medical university,kunming 650500,yunnan,china)
出处 《上海中医药大学学报》 CAS 2021年第1期83-92,共10页 Academic Journal of Shanghai University of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81660596,81660684,81760733,81960710) 云南省应用基础研究计划项目(2017FF117-013,2017FF116-003,2017FF117-015,2018FF001-005) 云南省重点研发计划项目(2019IB009) 云南省教育厅科学研究基金资助项目(2020Y0209)。
关键词 黄精丸 黄精 天冬 糖脂代谢 网络药理学 Huangjing Pill Polygonati Rhizoma Asparagi Radix glycolipid metabolism network pharmacology
  • 相关文献

参考文献9

二级参考文献80

  • 1张莹,李小宇,华琦.调脂中药的研究进展[J].张家口医学院学报,2001,18(2):109-110. 被引量:6
  • 2高翔,周蓉,张立实.玉米胚芽油辅助降血脂作用人群试验研究[J].现代预防医学,2005,32(6):598-599. 被引量:8
  • 3陈兴荣,赖泳,王成军.滇黄精对诱导性高血糖小鼠血糖影响的实验研究[J].时珍国医国药,2010,21(12):3163-3164. 被引量:22
  • 4张雅萍,祝之明,闫振成,钟健,王利娟,曹廷兵,聂海,杨华.代谢综合征大鼠肥胖特征及ERK1/2和p38MAPK的作用研究[J].解放军医学杂志,2006,31(8):794-797. 被引量:9
  • 5Kato A, Miura T. Hypoglycemic activity of Polygonati Rhizoma in nomal and diabetic mice [ J ]. Biol Pham Bull, 1993,16(11) :18-20.
  • 6Horii S, Fukase H. Synthesis of a-glucosidase inhibitiory activity of N-substituted valiolsmine derivatives as potential oral antidiabetic agents [ J ]. J Med Chem, 1986,29 ( 6 ) : 1038-1046.
  • 7Matsui T, Shimada M, Saito N. c-Glucosidase inhibition assay in an enzyme-immobilized amino-micrioplate [ J ]. Anal Sci,2009,25 (4) : 559-562.
  • 8Asano N. Glycosidase inhibition:update and perspectives on practical use [ J ]. Glycobio ,2003 : 13 ( 10 ) :93-104.
  • 9Holman R, Cull C A, Turner R C. A randomized double- blind trial of acarbose in type 2 diabetes shows improved glycemie control over 3 years( U. K. Prospective Diabetes Study 44) [ J]. Diabetes Care, 2004, 68 ( 11 ): 2239-2246.
  • 10Van de Laar F A, Lueassen P L, Akkermans R P. Alpha- glucosidase inhibitors for patients with type 2 diabetes results from a Cochrane systematic review and meta-analysis [ J]. Diabetes Care ,2005,28 C 1 ) : 154-63.

共引文献1623

同被引文献128

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部